Menlo Park, CA, United States of America

Purvesh Khatri

This inventor holds 11 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Leland Stanford Junior University, Technion Research & Development Foundation Ltd. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Purvesh Khatri. Retrieved from https://idiyas.com/inventor/purvesh-khatri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 90.9

 

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Stanford, CA (US) (2017 - 2022)
  • Menlo Park, CA (US) (2019 - 2023)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Purvesh Khatri: Innovator in Biomarker Research

Introduction

Purvesh Khatri is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of biomarker research, particularly in the context of organ transplants and critically ill patients. With a total of 11 patents, Khatri's work has the potential to revolutionize medical diagnostics and treatment.

Latest Patents

One of Khatri's latest patents focuses on protein and gene biomarkers for the rejection of organ transplants. This invention includes methods for determining a transplant category of a subject with a transplant. It uncovers common mechanisms of rejection injury across different tissue transplants, providing insights for rational drug design. The invention examines various sources of tissues from the patient to understand acute rejection mechanisms, utilizing both minimally invasive (blood) and non-invasive (urine for kidney allografts) monitoring techniques. The biomarkers identified can help determine the subject's transplant category, including acute allograft rejection, stable allograft, BK viremia, drug toxicity, and chronic allograft injury.

Another significant patent by Khatri involves biomarkers for predicting mortality in critically ill patients. This invention discloses biomarkers and methods for aiding diagnosis, prognosis, and treatment, particularly for patients suffering from sepsis, severe trauma, or burns. The use of these biomarkers can greatly enhance the prognosis and treatment strategies for critically ill patients.

Career Highlights

Khatri has worked with esteemed institutions such as Leland Stanford Junior University and Technion Research & Development Foundation Limited. His research has garnered attention for its innovative approach to understanding complex medical conditions through biomarker discovery.

Collaborations

Some of Khatri's notable coworkers include Timothy E. Sweeney and Minnie M. Sarwal. Their collaborative efforts have contributed to advancing the field of biomarker research and improving patient outcomes.

Conclusion

Purvesh Khatri's innovative work in biomarker research is paving the way for advancements in organ transplant management and critical care. His contributions are vital for enhancing diagnostic accuracy and treatment efficacy in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…